M. Gattinara

发表

Primary Sjögren syndrome: report of a 10 years old girl with local edema and positivity of anti SS-A and anti SS-B autoantibodies.

E. Shahi, C. Donati, M. Gattinara, 2011, Reumatismo.

Hyaluronic Acid Therapy in Hip OA Does Not Perform Equally in Osteoarthritis Secondary to Juvenile Idiopathic Arthritis When Compared to Primary Osteoarthritis: A 2-Year Preliminary Evaluation

R. Caporali, O. De Lucia, R. Cimaz, 2022, Advances in Therapy.

Validation of the Italian version of the Stanford Childhood Health Assessment Questionnaire for measuring functional status in children with chronic arthritis.

M. Gattinara, V. Gerloni, G. Calori, 1995, Clinical and experimental rheumatology.

[Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy].

M. Gattinara, I. Pontikaki, V. Gerloni, 2011, Reumatismo.

Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10 years.

R. Cimaz, M. Gattinara, V. Gerloni, 2000, The Journal of rheumatology.

Severe anemia associated with active systemic-onset juvenile rheumatoid arthritis successfully treated with recombinant human erythropoietin: a pilot study.

M. Gattinara, V. Gerloni, F. Fantini, 1992, Arthritis & Rheumatism.

Long Term Experience in Patients With JIA-Associated Uveitis in a Large Referral Center

L. Marelli, R. Cimaz, P. Nucci, 2021, Frontiers in Pediatrics.

FRI0550 Drug Survival and Reasons for Discontinuation of the First Course of Biological Therapy in 363 Juvenile Idiopathic Arthritis Patients

P. Boracchi, M. Gattinara, I. Pontikaki, 2014 .

Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients.

P. Boracchi, P. Meroni, C. Donati, 2014, Reumatismo.

Efficacy and safety profile of cyclosporin A in the treatment of juvenile chronic (idiopathic) arthritis. Results of a 10-year prospective study.

R. Cimaz, M. Gattinara, I. Pontikaki, 2001, Rheumatology.

Efﬁcacy and safety proﬁle of cyclosporin A in the treatment of juvenile chronic (idiopathic) arthritis. Results of a 10-year prospective study

R. Cimaz, M. Gattinara, I. Pontikaki, 2001 .

Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part one

J. Stinson, J. Jaremko, A. Goris, 2017, Pediatric Rheumatology.

[Side effects of anti-TNFalpha therapy in juvenile idiopathic arthritis].

M. Gattinara, I. Pontikaki, V. Gerloni, 2011, Reumatismo.

Evaluation by dual-photon absorptiometry of bone mineral loss in rheumatic children on long-term treatment with corticosteroids.

M. Gattinara, V. Gerloni, M. Gallazzi, 1991, Clinical and experimental rheumatology.

[Skeletal mineralization in a prepubertal female population affected by juvenile idiopathic arthritis].

R. Cimaz, M. Gattinara, V. Gerloni, 2011, Reumatismo.

Patients with juvenile idiopathic arthritis on TNF inhibitors exposed to COVID-19 family members

R. Cimaz, M. Gattinara, A. Marino, 2020, Seminars in Arthritis and Rheumatism.

Anti-CD 20 monoclonal antibody (rituximab) treatment for inflammatory ocular diseases.

P. Meroni, M. Gattinara, I. Pontikaki, 2011, Autoimmunity reviews.

[Temporomandibular joint involvement in juvenile idiopathic arthritis: treatment with an orthodontic appliance].

C. Bellintani, G. Farronato, P. Ghiringhelli, 2011, Reumatismo.

Remission in juvenile chronic arthritis: a cohort study of 683 consecutive cases with a mean 10 year followup.

R. Cimaz, M. Gattinara, V. Gerloni, 2003, The Journal of rheumatology.

Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations: similarities and differences

P. Meroni, E. Favalli, M. Gattinara, 2017, Clinical Rheumatology.

Henoch-Schönlein purpura following COVID-19 vaccine in a child: a case report

V. Fabiano, G. Zuccotti, M. Gattinara, 2022, Italian Journal of Pediatrics.

[Biological therapy with TNF-inhibitors in pediatric rheumatology. Review of the literature and personal experience].

M. Gattinara, I. Pontikaki, V. Gerloni, 2011, Reumatismo.

Focus on adverse events of tumour necrosis factor α blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients

M. Gattinara, I. Pontikaki, V. Gerloni, 2007, Annals of the rheumatic diseases.

Chronic Nonbacterial Osteomyelitis and Inflammatory Bowel Disease: A Literature Review-Based Cohort

S. Costi, R. Caporali, M. Gattinara, 2023, Children.

Biologics for the Treatment of Juvenile Idiopathic Arthritis.

M. Gattinara, V. Gerloni, D. Poddighe, 2019, Current medicinal chemistry.

Accuracy of Wallace Criteria for Clinical Remission in Juvenile Idiopathic Arthritis: a Cohort Study of 761 Consecutive Cases

M. Gattinara, V. Gerloni, A. Lurati, 2009, The Journal of Rheumatology.

Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trial

A. Martini, A. Pistorio, M. Gattinara, 2017, The Lancet.

Baseline ultrasound examination as possible predictor of relapse in patients affected by juvenile idiopathic arthritis (JIA)

Marcus John Beasley, O. De Lucia, R. Cimaz, 2018, Annals of the rheumatic diseases.

A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti-tumor necrosis factor alpha agents.

R. Cimaz, M. Gattinara, I. Pontikaki, 2006, Arthritis and rheumatism.

Relationship between delayed menarche and bone density in patients affected by juvenile idiopathic arthritis

M. Gattinara, V. Gerloni, A. Lurati, 2008, Pediatric Rheumatology Online Journal.

Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective study.

M. Gattinara, I. Pontikaki, V. Gerloni, 2005, Arthritis and rheumatism.

Arthritis : a Cohort Study of 761 Consecutive Cases Accuracy of Wallace Criteria for Clinical Remission in Juvenile Idiopathic

M. Gattinara, V. Gerloni, A. Lurati, 2009 .

Serum calprotectin (S100A8/9), clinical and ultrasound assessment in patients with juvenile idiopathic arthritis.

M. Mahler, P. Meroni, O. De Lucia, 2021, Clinical and experimental rheumatology.

Case report: Prader–Willi syndrome and inflammatory arthritis—An important consideration

R. Caporali, L. Marelli, O. De Lucia, 2023, Frontiers in Pediatrics.

Pyoderma gangrenosum following anti-TNF therapy in chronic recurrent multifocal osteomyelitis: drug reaction or cutaneous manifestation of the disease? A critical review on the topic with an emblematic case report

C. Moltrasio, M. Gattinara, A. Marzano, 2023, Frontiers in Medicine.

The natural history of hip involvement in juvenile rheumatoid arthritis: a radiological and magnetic resonance imaging follow-up study.

L. Aprile, M. Gattinara, A. Corradi, 1997, Revue du rhumatisme.

Primary Sjögren syndrome: report of a 10 years old girl with local edema and positivity of anti SS-A and anti SS-B autoantibodies.

E. Shahi, C. Donati, M. Gattinara, 2011, Reumatismo.

Collapsing Focal Segmental Glomerulosclerosis in a Patient with Juvenile Idiopathic Arthritis Treated with Leflunomide

P. Messa, R. Cerutti, M. Gattinara, 2015 .